Detected ·
Attune Neurosciences, Inc.
$8.3M—
Attune Neurosciences, Inc. and Adaptyx Biosciences have secured $8.3M in ARPA-H funding to develop the EVIDENT program — an initiative to objectively quantify and restore mental health using monitoring devices, ML models, and therapeutic ultrasound, without relying on traditional questionnaires.
- Website
- www.attuneneuro.com
- linkedin.com/company/attuneneuro
- Amount
- $8 300 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-18 04:06:51 UTC
- Signal ID
- 63f4c7ca-ee2b-4b57-9638-5f2121e7f298
As the API returns it
{
"id": "63f4c7ca-ee2b-4b57-9638-5f2121e7f298",
"created_at": "2026-08-18T04:06:51.096260Z",
"company_name": "Attune Neurosciences, Inc.",
"company_website_url": "www.attuneneuro.com",
"company_linkedin_url": "https://www.linkedin.com/company/attuneneuro",
"event_type": "funding",
"funding_amount": 8300000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Attune Neurosciences, Inc. and Adaptyx Biosciences have secured $8.3M in ARPA-H funding to develop the EVIDENT program — an initiative to objectively quantify and restore mental health using monitoring devices, ML models, and therapeutic ultrasound, without relying on traditional questionnaires.*"
}